Notably, SPP1 has been widely reported to be associated with macrophage infiltration, cancer-associated fibroblasts, poor prognosis in hepatocellular carcinoma, and resistance to sorafenib and lenvatinib [37–39]. This evidence concerns the gene SPP1 and hepatocellular carcinoma.